Calcium dysregulation in Alzheimer's disease

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 621-633

  Bojarski, Lukasz ^a   Herms, Jochen ^b   Kuznicki, Jacek ^a,c  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^b UNIVERSITY OF MUNICH   (Germany)

^c NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

amyloid; Alzheimer disease; Calcium signaling; Presenilins

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AMYLOID BETA PROTEIN; CALCIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; GAMMA SECRETASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PRESENILIN; RYANODINE RECEPTOR; TAU PROTEIN;

ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; COGNITIVE DEFECT; ENDOPLASMIC RETICULUM; HUMAN; MEMORY DISORDER; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CALCIUM; HOMEOSTASIS; HUMANS; PHOSPHORYLATION; TAU PROTEINS;

EID: 38349092352     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.10.002     Document Type: Review

References (147)

1. Andersen O.M., Reiche J., Schmidt V., Gotthardt M., Spoelgen R., Behlke J., von Arnim C.A., Breiderhoff T., Jansen P., Wu X., Bales K.R., Cappai R., Masters C.L., Gliemann J., Mufson E.J., Hyman B.T., Paul S.M., Nykjaer A., and Willnow T.E. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America, vol. 102 (2005) 13461-13466
2. Annaert W.G., Esselens C., Baert V., Boeve C., Snellings G., Cupers P., Craessaerts K., and De Strooper B. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32 (2001) 579-589
3. Arispe N., Pollard H.B., and Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [Aβ-(1-40)] in bilayer membranes. Proceedings of the National Academy of Sciences of the United States of America, vol. 90 (1993) 10573-10577
4. Arnaudeau S., Kelley W.L., Walsh Jr. J.V., and Demaurex N. Mitochondria recycle Ca(2+) to the endoplasmic reticulum and prevent the depletion of neighboring endoplasmic reticulum regions. J. Biol. Chem. 276 (2001) 29430-29439
5. Barrow P.A., Empson R.M., Gladwell S.J., Anderson C.M., Killick R., Yu X., Jefferys J.G., and Duff K. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 7 (2000) 119-126
6. Baskin F., Rosenberg R.N., Iyer L., Schellenberg G.D., Hynan L., and Nee L.E. Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation. J. Neurol. Sci. 183 (2001) 85-88
7. Begley J.G., Duan W., Chan S., Duff K., and Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72 (1999) 1030-1039
8. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1 (2000) 11-21
9. 2+-signals to Alzheimer's disease-related presenilin 2 in forebrain. Biochim. Biophys. Acta 1762 (2006) 66-72
10. Braunewell K.H., and Gundelfinger E.D. Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function. Cell Tissue Res. 295 (1999) 1-12
11. Buxbaum J.D., Choi E.K., Luo Y., Lilliehook C., Crowley A.C., Merriam D.E., and Wasco W. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4 (1998) 1177-1181
12. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., and Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
13. Buxbaum J.D., Ruefli A.A., Parker C.A., Cypess A.M., and Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proceedings of the National Academy of Sciences of the United States of America, vol. 91 (1994) 4489-4493
14. Cao X., and Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
15. Cardoso S.M., Santana I., Swerdlow R.H., and Oliveira C.R. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J. Neurochem. 89 (2004) 1417-1426
16. Carter J., and Lippa C.F. Beta-amyloid, neuronal death and Alzheimer's disease. Curr. Mol. Med. 1 (2001) 733-737
17. Cedazo-Minguez A., and Cowburn R.F. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J. Cell. Mol. Med. 5 (2001) 254-266
18. Cedazo-Minguez A., Popescu B.O., Ankarcrona M., Nishimura T., and Cowburn R.F. The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations. J. Biol. Chem. 277 (2002) 36646-36655
19. Chan S.L., Mayne M., Holden C.P., Geiger J.D., and Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 275 (2000) 18195-18200
20. Chui D.H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., Suzuki H., Araki W., Inoue H., Shirotani K., et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5 (1999) 560-564
21. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., and Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature (Lond.) 398 (1999) 518-522
22. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., von Figura K., and Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature (Lond.) 391 (1998) 387-390
23. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
24. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26 (2006) 6011-6018
25. Dewachter I., Ris L., Croes S., Borghgraef P., Devijver H., Voets T., Nilius B., Godaux E., and Van Leuven F. Modulation of synaptic plasticity and Tau phosphorylation by wild-type and mutant presenilin1. Neurobiol. Aging (2007) [Epub ahead of print]
26. Dewji N.N., Valdez D., and Singer S.J. The presenilins turned inside out: implications for their structures and functions. Proceedings of the National Academy of Sciences of the United States of America, vol. 101 (2004) 1057-1062
27. Doglio L.E., Kanwar R., Jackson G.R., Perez M., Avila J., Dingwall C., Dotti C.G., Fortini M.E., and Feiguin F. Gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. Neuron 50 (2006) 359-375
28. Eckert A., Schindowski K., Leutner S., Luckhaus C., Touchet N., Czech C., and Muller W.E. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice. Neurobiol. Dis. 8 (2001) 331-342
29. Etcheberrigaray R., Hirashima N., Nee L., Prince J., Govoni S., Racchi M., Tanzi R.E., and Alkon D.L. Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol. Dis. 5 (1998) 37-45
30. Evin G., Zhu A., Holsinger R.M., Masters C.L., and Li Q.X. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. J. Neurosci. Res. 74 (2003) 386-392
31. 2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J. Neurosci. Res. 76 (2004) 872-880
32. Fleming L.M., and Johnson G.V. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem. J. 309 Pt 1 (1995) 41-47
33. Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J., Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J., Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S., and Curtis D. Aph-1 and pen-2 are required for Notch pathway signalling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3 (2002) 85-97
34. Fu H., Li W., Lao Y., Luo J., Lee N.T., Kan K.K., Tsang H.W., Tsim K.W., Pang Y., Li Z., Chang D.C., Li M., and Han Y. Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels. J. Neurochem. 98 (2006) 1400-1410
35. Furukawa K., Guo Q., Schellenberg G.D., and Mattson M.P. Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52 (1998) 618-624
36. Gao Y., and Pimplikar S.W. The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signalling to the nucleus. Proceedings of the National Academy of Sciences of the United States of America, vol. 98 (2001) 14979-14984
37. Georgakopoulos A., Marambaud P., Efthimiopoulos S., Shioi J., Cui W., Li H.C., Schutte M., Gordon R., Holstein G.R., Martinelli G., Mehta P., Friedrich Jr. V.L., and Robakis N.K. Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4 (1999) 893-902
38. Glabe C.G. Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem. Sci. 29 (2004) 542-547
39. Goodman Y., and Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 128 (1994) 1-12
40. Guo Q., Christakos S., Robinson N., and Mattson M.P. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 3227-3232
41. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., and Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5 (1999) 101-106
42. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8 (1996) 379-383
43. Guo Q., Robinson N., and Mattson M.P. Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis. J. Biol. Chem. 273 (1998) 12341-12351
44. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17 (1997) 4212-4222
45. Hamid R., Kilger E., Willem M., Vassallo N., Kostka M., Bornhovd C., Reichert A.S., Kretzschmar H.A., Haass C., and Herms J. Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content. J. Neurochem. 102 (2007) 1264-1275
46. Hardy J., and Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science 282 (1998) 1075-1079
47. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
48. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., and Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, vol. 91 (1994) 3270-3274
49. Herms J., Schneider I., Dewachter I., Caluwaerts N., Kretzschmar H., and Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J. Biol. Chem. 278 (2003) 2484-2489
50. Hewavitharana T., Deng X., Soboloff J., and Gill D.L. Role of STIM and Orai proteins in the store-operated calcium signalling pathway. Cell Calcium 42 (2007) 173-182
51. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., and Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52 (2006) 831-843
52. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., and Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14 (1999) 419-427
53. Iacopino A.M., and Christakos S. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America, vol. 87 (1990) 4078-4082
54. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, vol. 91 (1994) 534-538
55. Johnson G.V., and Stoothoff W.H. Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117 (2004) 5721-5729
56. Johnston J.M., Burnett P., Thomas A.P., and Tezapsidis N. Calcium oscillations in type-1 astrocytes, the effect of a presenilin 1 (PS1) mutation. Neurosci. Lett. 395 (2006) 159-164
57. Kagan B.L., Azimov R., and Azimova R. Amyloid peptide channels. J. Membr. Biol. 202 (2004) 1-10
58. Kamal A., Stokin G.B., Yang Z., Xia C.H., and Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28 (2000) 449-459
59. Kang D.E., Soriano S., Xia X., Eberhart C.G., De Strooper B., Zheng H., and Koo E.H. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 110 (2002) 751-762
60. Karelson E., Fernaeus S., Reis K., Bogdanovic N., and Land T. Stimulation of G-proteins in human control and Alzheimer's disease brain by FAD mutants of APP(714-723): implication of oxidative mechanisms. J. Neurosci. Res. 79 (2005) 368-374
61. Kasri N.N., Kocks S.L., Verbert L., Hebert S.S., Callewaert G., Parys J.B., Missiaen L., and De Smedt H. Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. Cell Calcium 40 (2006) 41-51
62. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron. J. Neurosci. Res. 50 (1997) 522-530
63. Keller J.N., Guo Q., Holtsberg F.W., Bruce-Keller A.J., and Mattson M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18 (1998) 4439-4450
64. Khachaturian Z.S. Calcium hypothesis of Alzheimer's disease and brain aging. Ann. NY Acad. Sci. 747 (1994) 1-11
65. Kinoshita A., Whelan C.M., Berezovska O., and Hyman B.T. The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277 (2002) 28530-28536
66. Klein W.L., Krafft G.A., and Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends Neurosci. 24 (2001) 219-224
67. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24 (2004) 10191-10200
68. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3 (2002) 862-872
69. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 6448-6453
70. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., and Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proceedings of the National Academy of Sciences of the United States of America, vol. 96 (1999) 3922-3927
71. Landman N., Jeong S.Y., Shin S.Y., Voronov S.V., Serban G., Kang M.S., Park M.K., Di Paolo G., Chung S., and Kim T.W. Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism. Proceedings of the National Academy of Sciences of the United States of America, vol. 103 (2006) 19524-19529
72. Lanni C., Racchi M., Mazzini G., Ranzenigo A., Polotti R., Sinforiani E., Olivari L., Barcikowska M., Styczynska M., Kuznicki J., Szybinska A., Govoni S., Memo M., and Uberti D. Conformationally altered p53: a novel Alzheimer's disease marker?. Mol. Psychiatry (2007) [Epub ahead of print]
73. Layfield R. Does an inhibition of the ubiquitin/26S proteasome pathway of protein degradation underlie the pathogenesis of non-familial Alzheimer's disease?. Med. Hypotheses 56 (2001) 395-399
74. Leissring M.A., Akbari Y., Fanger C.M., Cahalan M.D., Mattson M.P., and LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149 (2000) 793-798
75. Leissring M.A., Murphy M.P., Mead T.R., Akbari Y., Sugarman M.C., Jannatipour M., Anliker B., Muller U., Saftig P., De Strooper B., Wolfe M.S., Golde T.E., and LaFerla F.M. A physiologic signalling role for the gamma-secretase-derived intracellular fragment of APP. Proceedings of the National Academy of Sciences of the United States of America, vol. 99 (2002) 4697-4702
76. Leissring M.A., Parker I., and LaFerla F.M. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4, 5-trisphosphate-mediated calcium signals. J. Biol. Chem. 274 (1999) 32535-32538
77. Leissring M.A., Paul B.A., Parker I., Cotman C.W., and LaFerla F.M. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signalling in Xenopus oocytes. J. Neurochem. 72 (1999) 1061-1068
78. Leissring M.A., Yamasaki T.R., Wasco W., Buxbaum J.D., Parker I., and LaFerla F.M. Calsenilin reverses presenilin-mediated enhancement of calcium signalling. Proceedings of the National Academy of Sciences of the United States of America, vol. 97 (2000) 8590-8593
79. Levitan D., Lee J., Song L., Manning R., Wong G., Parker E., and Zhang L. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signalling. Proceedings of the National Academy of Sciences of the United States of America, vol. 98 (2001) 12186-12190
80. Li D., Parks S.B., Kushner J.D., Nauman D., Burgess D., Ludwigsen S., Partain J., Nixon R.R., Allen C.N., Irwin R.P., Jakobs P.M., Litt M., and Hershberger R.E. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet. 79 (2006) 1030-1039
81. Litersky J.M., Johnson G.V., Jakes R., Goedert M., Lee M., and Seubert P. Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem. J. 316 Pt 2 (1996) 655-660
82. Maccioni R.B., Otth C., Concha I.I., and Munoz J.P. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur. J. Biochem. 268 (2001) 1518-1527
83. Malaplate-Armand C., Florent-Bechard S., Youssef I., Koziel V., Sponne I., Kriem B., Leininger-Muller B., Olivier J.L., Oster T., and Pillot T. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol. Dis. 23 (2006) 178-189
84. Marambaud P., and Robakis N.K. Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes, Brain, Behav. 4 (2005) 134-146
85. Marjaux E., Hartmann D., and De Strooper B. Presenilins in memory, Alzheimer's disease, and therapy. Neuron 42 (2004) 189-192
86. Mattson M.P. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. NY Acad. Sci. 747 (1994) 50-76
87. Mattson M.P. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25 (1994) 439-450
88. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
89. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., and Rydel R.E. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16 (1993) 409-414
90. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
91. Mattson M.P., Engle M.G., and Rychlik B. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol. Chem. Neuropathol. 15 (1991) 117-142
92. Mirzabekov T.A., Lin M.C., and Kagan B.L. Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271 (1996) 1988-1992
93. 2+ leak function of presenilin 1. J. Clin. Invest. 117 (2007) 1230-1239
94. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., and Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362 (1993) 75-79
95. Oertner T.G., and Matus A. Calcium regulation of actin dynamics in dendritic spines. Cell Calcium 37 (2005) 477-482
96. Okamoto T., Takeda S., Giambarella U., Murayama Y., Matsui T., Katada T., Matsuura Y., and Nishimoto I. Intrinsic signalling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease. Eur. Mol. Biol. Org. J. 15 (1996) 3769-3777
97. Pack-Chung E., Meyers M.B., Pettingell W.P., Moir R.D., Brownawell A.M., Cheng I., Tanzi R.E., and Kim T.W. Presenilin 2 interacts with sorcin, a modulator of the ryanodine receptor. J. Biol. Chem. 275 (2000) 14440-14445
98. Peskind E.R., Potkin S.G., Pomara N., Ott B.R., Graham S.M., Olin J.T., and McDonald S. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am. J. Geriatr. Psychiatry 14 (2006) 704-715
99. Peterson C., Ratan R.R., Shelanski M.L., and Goldman J.E. Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors. Proceedings of the National Academy of Sciences of the United States of America, vol. 83 (1986) 7999-8001
100. Pierrot N., Ghisdal P., Caumont A.S., and Octave J.N. Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J. Neurochem. 88 (2004) 1140-1150
101. Pierrot N., Santos S.F., Feyt C., Morel M., Brion J.P., and Octave J.N. Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. J. Biol. Chem. 281 (2006) 39907-39914
102. Popescu B.O., Cedazo-Minguez A., Popescu L.M., Winblad B., Cowburn R.F., and Ankarcrona M. Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 66 (2001) 122-134
103. Priller C., Dewachter I., Vassallo N., Paluch S., Pace C., Kretzschmar H.A., Van Leuven F., and Herms J. Mutant presenilin 1 alters synaptic transmission in cultured hippocampal neurons. J. Biol. Chem. 282 (2007) 1119-1127
104. Putney Jr. J.W. Capacitative calcium entry in the nervous system. Cell Calcium 34 (2003) 339-344
105. Querfurth H.W., and Selkoe D.J. Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33 (1994) 4550-4561
106. Raza M., Deshpande L.S., Blair R.E., Carter D.S., Sombati S., and DeLorenzo R.J. Aging is associated with elevated intracellular calcium levels and altered calcium homeostatic mechanisms in hippocampal neurons. Neurosci. Lett. 418 (2007) 77-81
107. Redmond L., and Ghosh A. Regulation of dendritic development by calcium signalling. Cell Calcium 37 (2005) 411-416
108. Rizzuto R., Duchen M.R., and Pozzan T. Flirting in little space: the ER/mitochondria Ca2+ liaison. Sci. STKE: signal transduction knowledge environment 2004 (2004) (re1)
109. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., Chen F., Shibata N., Lunetta K.L., Pardossi-Piquard R., Bohm C., Wakutani Y., Cupples L.A., Cuenco K.T., Green R.C., Pinessi L., Rainero I., Sorbi S., Bruni A., Duara R., Friedland R.P., Inzelberg R., Hampe W., Bujo H., Song Y.Q., Andersen O.M., Willnow T.E., Graff-Radford N., Petersen R.C., Dickson D., Der S.D., Fraser P.E., Schmitt-Ulms G., Younkin S., Mayeux R., Farrer L.A., and St George-Hyslop P. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39 (2007) 168-177
110. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., Gilis M., Geerts H., Kretzschmar H., Godaux E., Moechars D., Van Leuven F., and Herms J. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276 (2001) 11539-11544
111. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
112. Selkoe D.J. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140 (2004) 627-638
113. Sheehan J.P., Swerdlow R.H., Miller S.W., Davis R.E., Parks J.K., Parker W.D., and Tuttle J.B. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J. Neurosci. 17 (1997) 4612-4622
114. Shinozaki K., Maruyama K., Kume H., Tomita T., Saido T.C., Iwatsubo T., and Obata K. The presenilin 2 loop domain interacts with the mu-calpain C-terminal region. Int. J. Mol. Med. 1 (1998) 797-799
115. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., Zhao J., McConlogue L., and John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402 (1999) 537-540
116. 2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation. Brain Res. 949 (2002) 105-111
117. Smith I.F., Green K.N., and LaFerla F.M. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 38 (2005) 427-437
118. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 (2005) 1051-1058
119. Sokolov Y., Kozak J.A., Kayed R., Chanturiya A., Glabe C., and Hall J.E. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J. Gen. Physiol. 128 (2006) 637-647
120. Stabler S.M., Ostrowski L.L., Janicki S.M., and Monteiro M.J. A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. J. Cell Biol. 145 (1999) 1277-1292
121. Steiner H., and Haass C. Intramembrane proteolysis by presenilins. Nat. Rev. Mol. Cell Biol. 1 (2000) 217-224
122. Steiner H., Winkler E., Edbauer D., Prokop S., Basset G., Yamasaki A., Kostka M., and Haass C. PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277 (2002) 39062-39065
123. Stokin G.B., and Goldstein L.S. Axonal transport and Alzheimer's disease. Annu. Rev. Biochem. 75 (2006) 607-627
124. Stutzmann G.E. Calcium dysregulation, IP3 signalling, and Alzheimer's disease. Neuroscientist 11 (2005) 110-115
125. Stutzmann G.E., Smith I., Caccamo A., Oddo S., LaFerla F.M., and Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J. Neurosci. 26 (2006) 5180-5189
126. Sulger J., Dumais-Huber C., Zerfass R., Henn F.A., and Aldenhoff J.B. The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia. Biol. Psychiatry 45 (1999) 737-742
127. Supnet C., Grant J., Kong H., Westaway D., and Mayne M. Abeta 1-42 increases ryanodine receptor-3 expression and function in TgCRND8 mice. J. Biol. Chem. (2006)
128. Swanson T.L., Knittel L.M., Coate T.M., Farley S.M., Snyder M.A., and Copenhaver P.F. The insect homologue of the amyloid precursor protein interacts with the heterotrimeric G protein Go alpha in an identified population of migratory neurons. Dev. Biol. 288 (2005) 160-178
129. Tamagno E., Bardini P., Guglielmotto M., Danni O., and Tabaton M. The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41 (2006) 202-212
130. Tandon A., Rogaeva E., Mullan M., and St George-Hyslop P.H. Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins. Curr. Opin. Neurol. 13 (2000) 377-384
131. Tariot P.N., Farlow M.R., Grossberg G.T., Graham S.M., McDonald S., and Gergel I. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. J. Am. Med. Assoc. 291 (2004) 317-324
132. Tatebayashi Y., Takeda M., Kashiwagi Y., Okochi M., Kurumadani T., Sekiyama A., Kanayama G., Hariguchi S., and Nishimura T. Cell-cycle-dependent abnormal calcium response in fibroblasts from patients with familial Alzheimer's disease. Dementia 6 (1995) 9-16
133. Thibault O., Gant J.C., and Landfield P.W. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6 (2007) 307-317
134. Thibault O., and Landfield P.W. Increase in single L-type calcium channels in hippocampal neurons during aging. Science 272 (1996) 1017-1020
135. Tolar M., Keller J.N., Chan S., Mattson M.P., Marques M.A., and Crutcher K.A. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J. Neurosci. 19 (1999) 7100-7110
136. Townsend M., Shankar G.M., Mehta T., Walsh D.M., and Selkoe D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572 (2006) 477-492
137. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126 (2006) 981-993
138. + exchanger. Neurobiol. Dis. 8 (2001) 289-298
139. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., and Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 (1999) 735-741
140. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (Lond.) 416 (2002) 535-539
141. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., and Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924 (2002) 133-140
142. Wang X.S., and Gruenstein E. Rapid elevation of neuronal cytosolic calcium by apolipoprotein E peptide. J. Cell. Physiol. 173 (1997) 73-83
143. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack-Chung E., Handler M., Shen J., Xia W., Tesco G., Saunders A.J., Ding K., Frosch M.P., Tanzi R.E., and Kim T.W. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27 (2000) 561-572
144. Zatti G., Burgo A., Giacomello M., Barbiero L., Ghidoni R., Sinigaglia G., Florean C., Bagnoli S., Binetti G., Sorbi S., Pizzo P., and Fasolato C. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 39 (2006) 539-550
145. Zatti G., Ghidoni R., Barbiero L., Binetti G., Pozzan T., Fasolato C., and Pizzo P. The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores. Neurobiol. Dis. 15 (2004) 269-278
146. Zekanowski C., Religa D., Graff C., Filipek S., and Kuznicki J. Genetic aspects of Alzheimer's disease. Acta Neurobiol. Exp. (Warsz.) 64 (2004) 19-31
147. Zekanowski C., Styczynska M., Peplonska B., Gabryelewicz T., Religa D., Ilkowski J., Kijanowska-Haladyna B., Kotapka-Minc S., Mikkelsen S., Pfeffer A., Barczak A., Luczywek E., Wasiak B., Chodakowska-Zebrowska M., Gustaw K., Laczkowski J., Sobow T., Kuznicki J., and Barcikowska M. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland. Exp. Neurol. 184 (2003) 991-996